Two-phase validation sampling via principal components to improve efficiency in multi-model estimation from error-prone biomedical databases
基于主成分的两阶段验证抽样：提升多模型估计效率AI 解读 ↓
← 返回论文列表与筛选
阅读说明
本页整理公开书目信息，不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成，未完成全文核验，可能有误；具体假设、证明与结论请核对原文。摘要保留来源文本，未经模型改写。
DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要；缺少可靠材料时保留待补状态。
本页为预印本版本；arXiv 收录、作者填写的期刊信息以及作者既有发表经历，都不单独证明本篇已接收。作者发表记录按 OpenAlex 身份与完整姓名、本站覆盖期刊 ISSN 及正式卷期核对，只展示已核实例，档案仍可能误合并。
引用量采用 OpenAlex 单条关联记录，不合计多个记录；关联记录可能包含正式发表版本，不等于此版本单独引用。缺失不视为零，引用指标不代表论文质量。
关注作者按书目中的完整姓名匹配，同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列，再参考通用方法与发表日期。
分类依据与纠错
AI 根据所提供的论文材料归类：摘要聚焦两阶段验证抽样设计与测量误差校正，属于生物医学统计方法，未直接对应所给微观、宏观或金融领域细分，故留空。
反馈分类问题
正在核对关联版本…
代码、数据与补充材料
正在核对对应版本的资源…
关注这篇论文的作者
基于主成分的两阶段验证抽样：提升多模型估计效率
- 研究问题
- 摘要称，研究如何在两阶段抽样中设计第二阶段验证样本，使其在同时关注多个分析模型时仍能高效估计易错协变量的效应，而非只优化单一模型。
- 方法与思路
- 作者提出将极端尾部抽样（ETS）扩展到多模型情形：先用主成分分析概括各模型易错暴露的变异，再抽取第一主成分取值最极端的个体进入第二阶段验证；通过模拟和对NHANES数据的应用评估该策略。
- 材料陈述的贡献
- 摘要称该策略可在多个目标模型上同时获得效率提升，且在测量误差相关或异质等情形下优势仍存在；作者主张验证研究设计不应只聚焦单一模型，降维有助于该策略扩展到含大量易错暴露的大数据场景。
- 阅读关注点
- 应核对主成分的构造与选取规则、极端尾部的截断阈值、多模型效率的衡量指标，以及模拟设定与NHANES应用中误差结构是否与理论假设一致。
- 阅读边界
- 这是arXiv预印本，未经同行评审验证；摘要未说明识别假设、理论性质、具体效率数值与代码，不能据此判断方法的一般最优性或实际适用边界。
原文摘要
Two-phase sampling offers a cost-effective way to validate error-prone covariate measurements in biomedical databases. Inexpensive or easy-to-obtain information is collected for the entire study in Phase I. Then, a subset of patients undergoes cost-intensive validation (e.g., expert chart review) to collect more accurate data in Phase II. When balancing primary and secondary analyses, competing models and priorities can result in poorly defined objectives for the most informative Phase II sampling criterion. Extreme tail sampling (ETS), wherein patients with the smallest and largest values of a particular quantity (like a covariate or residual) are selected, can offer great statistical efficiency in two-phase studies when focusing on a single analytic objective by targeting observations with the biggest contributions to the Fisher information. We propose an intuitive, easy-to-use approach that extends ETS to balance and prioritize explaining the largest amount of variability across multiple models of interest. Using principal components analysis, we succinctly summarize the inherent variability of all models' error-prone exposures. Then, we sample patients with the most extreme values of the first principal component for validation. Through extensive simulations and an application to the National Health and Nutrition Examination Survey (NHANES), the proposed strategy offered simultaneous efficiency gains across multiple models of interest. Its advantages persisted across various real-world scenarios, including correlated or heterogeneous measurement error. When designing a validation study, concentrating on a single model may be short-sighted. Strategically allocating resources more broadly balances multiple analytical goals simultaneously. Employing dimension reduction before sampling will allow this strategy to scale up well to big-data applications with many error-prone exposures.